RI
RTW Investments’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,463,201
| Closed | -$137M | – | 72 |
|
|
2023
Q4 | $137M | Hold |
3,463,201
| – | – | 2.15% | 17 |
|
|
2023
Q3 | $95.3M | Hold |
3,463,201
| – | – | 2.01% | 18 |
|
|
2023
Q2 | $118M | Buy |
3,463,201
+378,986
| +12% | +$12.9M | 2.24% | 18 |
|
|
2023
Q1 | $111M | Hold |
3,084,215
| – | – | 2.31% | 16 |
|
|
2022
Q4 | $137M | Hold |
3,084,215
| – | – | 2.81% | 14 |
|
|
2022
Q3 | $86.7M | Hold |
3,084,215
| – | – | 2% | 17 |
|
|
2022
Q2 | $83.2M | Hold |
3,084,215
| – | – | 2.15% | 15 |
|
|
2022
Q1 | $105M | Sell |
3,084,215
-837,364
| -21% | -$28.5M | 2.17% | 18 |
|
|
2021
Q4 | $152M | Buy |
3,921,579
+12,632
| +0.3% | +$488K | 2.21% | 14 |
|
|
2021
Q3 | $211M | Hold |
3,908,947
| – | – | 3.18% | 8 |
|
|
2021
Q2 | $131M | Hold |
3,908,947
| – | – | 1.97% | 14 |
|
|
2021
Q1 | $80.5M | Buy |
3,908,947
+486,092
| +14% | +$10M | 1.26% | 27 |
|
|
2020
Q4 | $60M | Buy |
3,422,855
+302,718
| +10% | +$5.3M | 1.01% | 30 |
|
|
2020
Q3 | $46.3M | Buy |
3,120,137
+510,137
| +20% | +$7.57M | 1.11% | 27 |
|
|
2020
Q2 | $33.9M | Buy |
+2,610,000
| New | +$33.9M | 0.95% | 32 |
|
|
2017
Q2 | – | Sell |
-241,699
| Closed | -$873K | – | 29 |
|
|
2017
Q1 | $873K | Buy |
241,699
+2,037
| +0.8% | +$7.36K | 0.23% | 24 |
|
|
2016
Q4 | $848K | Sell |
239,662
-1,003,502
| -81% | -$3.55M | 0.32% | 23 |
|
|
2016
Q3 | $5.02M | Sell |
1,243,164
-21,063
| -2% | -$85.1K | 1.52% | 18 |
|
|
2016
Q2 | $5.55M | Buy |
1,264,227
+274,851
| +28% | +$1.21M | 1.9% | 17 |
|
|
2016
Q1 | $3.74M | Buy |
989,376
+352,138
| +55% | +$1.33M | 1.36% | 18 |
|
|
2015
Q4 | $9.99M | Sell |
637,238
-81,491
| -11% | -$1.28M | 3.25% | 12 |
|
|
2015
Q3 | $7.58M | Buy |
718,729
+247,175
| +52% | +$2.61M | 2.35% | 14 |
|
|
2015
Q2 | $11.9M | Buy |
+471,554
| New | +$11.9M | 3.46% | 13 |
|